DHR vs ORCL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Oracle Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Oracle Corporation · Technology
$149.12
+45.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
ORCL has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
ORCL |
| Current Price |
$221.12 |
$149.12 |
| Fair Value Estimate |
$286.52 |
$216.22 |
| Upside to Fair Value |
+29.6%
|
+45.0%
|
| Market Cap |
$155.4B |
$429.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
14.6x
|
| Price / Sales |
6.2x
|
6.0x
|
| Price / FCF |
28.5x
|
—
|
| Revenue Growth YoY |
+5.5%
|
+29.6%
|
| Gross Margin |
58.5%
|
63.9%
|
| Operating Margin |
20.4%
|
32.4%
|
| Return on Equity |
7.7%
|
42.6%
|
| Dividend Yield |
0.65% |
1.34% |
| FCF Yield |
3.51%
|
—
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
| Metric |
DHR |
ORCL |
| Zone Low |
$214.89 |
$162.16 |
| Zone High |
$243.54 |
$183.79 |
| In Buy Zone? |
Yes
|
Yes
|